Principal, Business Development and Commercialization

Responsibilities

• Proactively engage researchers within the assigned portfolio to understand research priorities and advance commercialization by translating research activities into executable licensing and sponsored research opportunities
• Drive deal flow and contract execution activities in a collaborative team environment, with accountability for timely negotiation and completion of licensing and sponsored research agreements.
• Support and lead opportunities for UHN commercialization funds and external ecosystem funding, as required.
• Work closely with Licensing & Commercialization, IP Management, Marketing, Operations, Research Legal, and the UHN Foundation to ensure contracts align with institutional policies while enabling rapid deal execution.
• Minimum of 10 years of relevant business experience or equivalent
• Completion of a Master's degree in oncology, immuno-oncology, or a related field, preferably with a translational research and or commercialization specialization or recognized equivalent experience required; PhD and/or MBA highly preferred
• Demonstrated expertise in clinical and translational research environments, with strong working knowledge of Clinical oncology, Oncology broadly
• Experience in the negotiation and

Benefits

Additional Information

*Repost* Union: Non-Union Number of vacancies: 1 New or Replacement Position: New Site: Mars/Hybrid Department: Commercialization Reports to: Ernest Ho Salary Range: $115,730 to $165,730 per annum Hours: 37.5 Shifts: Days Status: Temporary Full-Time Closing Date: June 22, 2026 Position Summary: Research at UHN is comprised of two major institutes: Princess Margaret Cancer Centre, and UHN Research Institutes. Princess Margaret Cancer Centre is where cutting edge oncology research is moved forward every day towards our mission of impacting patients globally. UHN Research Institutes is internationally recognized for its multidisciplinary biomedical research which encompasses activity across the UHN sites (other than Princess Margaret Cancer Centre) and drives the convergence of care, research, and education across a broad scope of disease fields and disciplines; as such it is a cornerstone of UHN's innovation ecosystem. These areas include Krembil Brain Institute, Schroeder Arthritis Institute, Donald K. Johnson Eye Institute, Peter Munk Cardiac Centre, KITE Research Institute, McEwen Stem Cell Institute, Ajmera Transplant Centre, and The Institute for Education Research, as well as research in respiratory health, metabolism and organ function, and health systems and policy. UHN's commercialization successes include the Medly cardiac digital health platform, EVLP lung transplant system, Adela Bio Inc., and more. These companies, first incubated within UHN, are among many others that have collectively injected more than $5 billion into the economy. among others, which have reshaped patient care and global standards in their respective fields. The Business Development and Commercialization Principal will play a key role in advancing UHN's research commercialization objectives including driving efficient execution and timely turnaround of licensing, sponsored research, and other research‑related agreements across his or her assigned portfolio primarily within the Princess Margaret Cancer Centre. This role requires a dynamic, commercially minded professional with strong academic credentials, demonstrated contract negotiation expertise, and the ability to manage complex stakeholder relationships in fast‑paced research and industry environments. The Principal is responsible for maximizing the commercial success of research conducted within their assigned portfolio. In close collaboration with the Head of Business Development & Commercialization, Principal Investigators, Institute Directors, and research teams, the Principal also supports end‑to‑end revenue generation activities, including opportunity evaluation, IP protection, marketing, licensing, and company formation. Depending on the stage of each asset within the portfolio, the Principal assesses market potential, develops IP and marketing strategies, engages pharmaceutical and biotechnology partners, and leads the negotiation and execution of sponsored research agreements, licensing agreements, and related term sheets, with a strong emphasis on efficient deal structuring and timely contract closure. A key focus of this role is improving the efficiency and turnaround time of sponsored research agreements and industry licensing, balancing institutional risk management with the need to rapidly enable industry‑academic collaborations.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at Universityhealthnetwork? Share your experience